Woodruff Emlen
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2005First federal award
$1.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $1.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 1, 2006 | NIH | SBIR/STTR Phase I The Use of Complement Inhibitors as therapeutic agents in AMD | $175K | TALIGEN THERAPEUTICS INC |
| Sep 1, 2005 | NIH | SBIR/STTR Phase I Targeted Complement Inhibitors as Therapeutic Agents | $179K | TALIGEN THERAPEUTICS INC |
| Aug 15, 2005 | NIH | SBIR/STTR Phase I Monoclonal Antibody to Factor B as Therapeutic in Asthma | $280K | TALIGEN THERAPEUTICS INC |
| Aug 15, 2005 | NIH | SBIR/STTR Phase I Monoclonal antibody to Factor B as a Therapeutic in Asthma | $288K | TALIGEN THERAPEUTICS INC |
| Apr 15, 2005 | NIH | SBIR/STTR Phase I A Novel Complement Inhibitor for Rheumatoid Arthritis | $97K | TALIGEN THERAPEUTICS INC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#409
Awards as PI#156
Patents#27
Companies
- TALIGEN THERAPEUTICS INCLinked by awards
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.